Habibah A. Wahab

Prof. Habibah A. Wahab

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SISyahrul Imran
Syahrul Imran
MTMuhammad Taha
Muhammad Taha
NINor Hadiani Ismail
Nor Hadiani Ismail
SKSyed Muhammad Kashif
Syed Muhammad Kashif
FRFazal Rahim
Fazal Rahim
HWHabibah A. Wahab
Habibah A. Wahab

1 February 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SMSuriyati Mohamad
Suriyati Mohamad
NZNabihah Mohd Zin
Nabihah Mohd Zin
HWHabibah A. Wahab
Habibah A. Wahab
PIPazilah Ibrahim
Pazilah Ibrahim
SSShaida Fariza Sulaiman
Shaida Fariza Sulaiman
SNSiti Suraiya Md. Noor
Siti Suraiya Md. Noor

19 October 2017 in Cancer Nanotechnology
Verified
Journal Article
Open access
PDF file
Zahraa YOUSSEFZahraa YOUSSEF
Zahraa YOUSSEF
RVRegis Vanderesse
Regis Vanderesse
LCLudovic Colombeau
Ludovic Colombeau
FBFrancis Baros
Francis Baros
TRThibault Roques-Carmes
Thibault Roques-Carmes
AGAmirah Mohd Gazzali
Amirah Mohd Gazzali
Nanoparticles (NPs) have been shown to have good ability to improve the targeting and delivery of therapeutics. In the field of photodynamic therapy (PDT), this targeting advantage of NPs could help ensure drug delivery at specific sites. Among the commonly reported NPs for PDT applications, NPs from zinc oxide, titanium dioxide, and fullerene are commonly reported. In addition, graphene has also been reported to be used as NPs albeit being relatively new to this field. In this context, the present review is organized by these different NPs and contains numerous research works related to PDT applications. The effectiveness of these NPs for PDT is discussed in detail by collecting all essential information described in the literature. The information thus assembled could be useful in designing new NPs specific for PDT and/or PTT applications in the future.

1 April 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YKYalda Kia
Yalda Kia
HOHasnah Osman
Hasnah Osman
SRSuresh Kumar Raju
Suresh Kumar Raju
VMVikneswaran Murugaiyah
Vikneswaran Murugaiyah
ABAlireza Basiri
Alireza Basiri
CBChoi Sy Bing
Choi Sy Bing

1 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
MFMuhammad Fauzi
Muhammad Fauzi
NINur Kusaira Ikram
Nur Kusaira Ikram
AGAmirah Mohd Gazzali
Amirah Mohd Gazzali
HWHabibah A. Wahab
Habibah A. Wahab
Over the years, coronaviruses (CoV) have posed a severe public health threat, causing an increase in mortality and morbidity rates throughout the world. The recent outbreak of a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the current Coronavirus Disease 2019 (COVID-19) pandemic that affected more than 215 countries with over 23 million cases and 800,000 deaths as of today. The situation is critical, especially with the absence of specific medicines or vaccines; hence, efforts toward the development of anti-COVID-19 medicines are being intensively undertaken. One of the potential therapeutic targets of anti-COVID-19 drugs is the angiotensin-converting enzyme 2 (ACE2). ACE2 was identified as a key functional receptor for CoV associated with COVID-19. ACE2, which is located on the surface of the host cells, binds effectively to the spike protein of CoV, thus enabling the virus to infect the epithelial cells of the host. Previous studies showed that certain flavonoids exhibit angiotensin-converting enzyme inhibition activity, which plays a crucial role in the regulation of arterial blood pressure. Thus, it is being postulated that these flavonoids might also interact with ACE2. This postulation might be of interest because these compounds also show antiviral activity in vitro. This article summarizes the natural flavonoids with potential efficacy against COVID-19 through ACE2 receptor inhibition.

31 July 2022 in Polymers
Verified
Journal Article
Open access
PDF file
HUHassaan Umar
Hassaan Umar
HWHabibah A. Wahab
Habibah A. Wahab
AGAmirah Mohd Gazzali
Amirah Mohd Gazzali
HTHafsa Tahir
Hafsa Tahir
WAWaqas Ahmad
Waqas Ahmad
Because of the extraordinary advancements in biomedical nanotechnology over the last few decades, traditional drug delivery systems have been transformed into smart drug delivery systems that respond to stimuli. These well-defined nanoplatforms can boost therapeutic targeting efficacy while reducing the side effects/toxicities of payloads, which are crucial variables for enhancing patient compliance by responding to specific internal or external triggers. Cubosomes are lipid-based nano systems that are analogous to well-known vesicular systems, such as lipo- and niosomes. They could be used as part of a unique drug delivery system that includes hydro-, lipo-, and amphiphilic drug molecules. In this review, we critically analyze the relevant literature on cubosomesregarding theories of cubosomeself-assembly, composition, and manufacturing methods, with an emphasis on tumor-targeted drug delivery applications. Due to the bioadhesive and -compatible nature of cubosome dispersion, this review also focuses on a variety of drug delivery applications, including oral, ophthalmic and transdermal.